blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2528611

EP2528611 - A COMPOSITION FOR USE IN THE THERAPY OF LACTOSE INTOLERANCE OR CONDITIONS ARISING FROM LACTASE DEFICIENCY [Right-click to bookmark this link]
StatusOpposition rejected
Status updated on  07.04.2017
Database last updated on 19.10.2024
FormerThe patent has been granted
Status updated on  20.12.2016
Most recent event   Tooltip12.10.2018Lapse of the patent in a contracting state
New state(s): AL
published on 14.11.2018  [2018/46]
Applicant(s)For all designated states
Vitacare GmbH & Co. KG
Konrad-Adenauer-Allee 8-10
61118 Bad Vilbel / DE
[2012/49]
Inventor(s)01 / WYROBNIK, Daniel, Henry
Justinianstrasse 4
60322 Frankfurt / DE
02 / WYROBNIK, Isaac, Harry
Gottfried-Keller str. 90
60431 Frankfurt / DE
 [2012/49]
Representative(s)Hutchins, Michael Richard, et al
Schlich
9 St Catherine's Road
Littlehampton, West Sussex BN17 5HS / GB
[N/P]
Former [2013/12]Hutchins, Michael Richard, et al
Schlich LLP
9 St. Catherine's Road
Littlehampton
West Sussex BN17 5HS / GB
Former [2012/49]Hutchins, Michael Richard
Schlich LLP
34 New Road
Littlehampton
West Sussex BN17 5AT / GB
Application number, filing date11707070.604.02.2011
WO2011EP00510
Priority number, dateEP2010000416120.04.2010         Original published format: EP 10004161
US20100338763P24.02.2010         Original published format: US 338763 P
DE2010100958226.02.2010         Original published format: DE102010009582
DE2010100808315.02.2010         Original published format: DE102010008083
DE2010100728908.02.2010         Original published format: DE102010007289
DE2010100730408.02.2010         Original published format: DE102010007304
DE2010100714205.02.2010         Original published format: DE102010007142
[2012/49]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011095339
Date:11.08.2011
Language:EN
[2011/32]
Type: A1 Application with search report 
No.:EP2528611
Date:05.12.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 11.08.2011 takes the place of the publication of the European patent application.
[2012/49]
Type: B1 Patent specification 
No.:EP2528611
Date:19.03.2014
Language:EN
[2014/12]
Search report(s)International search report - published on:EP11.08.2011
ClassificationIPC:A61K35/74, A61K38/47
[2012/49]
CPC:
A61K35/74 (EP,US); A61K35/747 (CN,US); A61K35/744 (CN,US);
A61K38/47 (EP,CN,US); A61P1/00 (EP); A61P1/14 (EP);
A61P3/00 (EP); C12Y302/01108 (CN,US) (-)
C-Set:
A61K35/744, A61K2300/00 (CN);
A61K35/747, A61K2300/00 (CN);
A61K35/74, A61K2300/00 (EP,US);
A61K38/47, A61K2300/00 (US,EP,CN)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2012/49]
Extension statesBA28.08.2012
ME28.08.2012
TitleGerman:ZUSAMMENSETZUNG FÜR DIE THERAPIE VON LAKTOSEUNVERTRÄGLICHKEIT ODER LEIDEN INFOLGE VON LAKTOSEMANGEL[2012/49]
English:A COMPOSITION FOR USE IN THE THERAPY OF LACTOSE INTOLERANCE OR CONDITIONS ARISING FROM LACTASE DEFICIENCY[2012/49]
French:MOYEN POUR L'APPLICATION EN CAS DE MANQUE EN LACTASE ET D'INTOLÉRANCE AU LACTOSE[2013/41]
Former [2012/49]COMPOSITION DESTINÉE À TRAITER L'INTOLÉRANCE AU LACTOSE OU DES ÉTATS PATHOLOGIQUES DUS À UNE DÉFICIENCE EN LACTASE
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase28.08.2012National basic fee paid 
28.08.2012Designation fee(s) paid 
28.08.2012Examination fee paid 
Examination procedure06.09.2011Request for preliminary examination filed
International Preliminary Examining Authority: EP
28.08.2012Examination requested  [2012/49]
18.10.2012Amendment by applicant (claims and/or description)
13.09.2013Communication of intention to grant the patent
22.01.2014Fee for grant paid
22.01.2014Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  13.09.2013
Opposition(s)Opponent(s)01  19.12.2014  08.01.2015  ADMISSIBLE
N.V. NUTRICIA
Eerste Stationsstraat 186
2712 HM Zoetermeer / NL
Opponent's representative
Nederlandsch Octrooibureau
P.O. Box 29720
2502 LS The Hague / NL
 [2016/42]
Former [2015/05]
Opponent(s)01  19.12.2014   
N.V. NUTRICIA
Eerste Stationsstraat 186
2712 HM Zoetermeer / NL
Opponent's representative
Meekel, Arthur Augustinus P.
Nederlandsch Octrooibureau P.O. Box 29720
2502 LS Den Haag / NL
23.01.2015Invitation to proprietor to file observations on the notice of opposition
02.06.2015Reply of patent proprietor to notice(s) of opposition
27.10.2016Legal effect of rejection of opposition [2017/19]
27.10.2016Date of oral proceedings
21.12.2016Despatch of minutes of oral proceedings
21.12.2016Date of despatch of rejection of opposition
Fees paidRenewal fee
07.02.2013Renewal fee patent year 03
23.01.2014Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL19.03.2014
CY19.03.2014
EE19.03.2014
HR19.03.2014
LT19.03.2014
LV19.03.2014
MC19.03.2014
MK19.03.2014
MT19.03.2014
RO19.03.2014
RS19.03.2014
SI19.03.2014
SK19.03.2014
SM19.03.2014
BG19.06.2014
NO19.06.2014
GR20.06.2014
IS19.07.2014
LU04.02.2015
[2018/46]
Former [2018/31]CY19.03.2014
EE19.03.2014
HR19.03.2014
LT19.03.2014
LV19.03.2014
MC19.03.2014
MK19.03.2014
MT19.03.2014
RO19.03.2014
RS19.03.2014
SI19.03.2014
SK19.03.2014
SM19.03.2014
BG19.06.2014
NO19.06.2014
GR20.06.2014
IS19.07.2014
LU04.02.2015
Former [2017/38]CY19.03.2014
EE19.03.2014
HR19.03.2014
LT19.03.2014
LV19.03.2014
MC19.03.2014
MT19.03.2014
RO19.03.2014
RS19.03.2014
SI19.03.2014
SK19.03.2014
SM19.03.2014
BG19.06.2014
NO19.06.2014
GR20.06.2014
IS19.07.2014
LU04.02.2015
Former [2017/03]CY19.03.2014
EE19.03.2014
HR19.03.2014
LT19.03.2014
LV19.03.2014
MC19.03.2014
MT19.03.2014
RO19.03.2014
RS19.03.2014
SI19.03.2014
SK19.03.2014
BG19.06.2014
NO19.06.2014
GR20.06.2014
IS19.07.2014
LU04.02.2015
Former [2016/28]CY19.03.2014
EE19.03.2014
HR19.03.2014
LT19.03.2014
LV19.03.2014
MC19.03.2014
RO19.03.2014
RS19.03.2014
SI19.03.2014
SK19.03.2014
BG19.06.2014
NO19.06.2014
GR20.06.2014
IS19.07.2014
LU04.02.2015
Former [2015/46]CY19.03.2014
EE19.03.2014
HR19.03.2014
LT19.03.2014
LV19.03.2014
MC19.03.2014
RO19.03.2014
RS19.03.2014
SI19.03.2014
SK19.03.2014
BG19.06.2014
NO19.06.2014
IS19.07.2014
LU04.02.2015
Former [2015/44]CY19.03.2014
EE19.03.2014
HR19.03.2014
LT19.03.2014
LV19.03.2014
RO19.03.2014
RS19.03.2014
SI19.03.2014
SK19.03.2014
BG19.06.2014
NO19.06.2014
IS19.07.2014
LU04.02.2015
Former [2015/36]CY19.03.2014
EE19.03.2014
HR19.03.2014
LT19.03.2014
LV19.03.2014
RO19.03.2014
RS19.03.2014
SI19.03.2014
SK19.03.2014
BG19.06.2014
NO19.06.2014
IS19.07.2014
Former [2014/50]CY19.03.2014
EE19.03.2014
HR19.03.2014
LT19.03.2014
LV19.03.2014
RO19.03.2014
RS19.03.2014
SK19.03.2014
BG19.06.2014
NO19.06.2014
IS19.07.2014
Former [2014/49]CY19.03.2014
EE19.03.2014
HR19.03.2014
LT19.03.2014
LV19.03.2014
RO19.03.2014
RS19.03.2014
BG19.06.2014
NO19.06.2014
IS19.07.2014
Former [2014/48]CY19.03.2014
EE19.03.2014
HR19.03.2014
LT19.03.2014
LV19.03.2014
RS19.03.2014
BG19.06.2014
NO19.06.2014
Former [2014/41]CY19.03.2014
HR19.03.2014
LT19.03.2014
LV19.03.2014
RS19.03.2014
NO19.06.2014
Former [2014/37]CY19.03.2014
LT19.03.2014
NO19.06.2014
Former [2014/36]LT19.03.2014
NO19.06.2014
Cited inInternational search[XI]US6008027  (LANGNER BRUCE J [US]) [X] 1 * Ansprüche 1-8, Abstrakt * [I] 2,4-19;
 [A]US6410018  (EISENHARDT PETER F [US], et al) [A] 1-21 * abstract, column 3, line 19 and last para, claims 1-4, 12-16, figures 1-2 *;
 [XI]WO2004089290  (PHARMACHEM LAB INC [US], et al) [X] 1,20 * claims 1-12, 15-16, 22, page 4, para 1, page 15, lines 20-21, page 16, lines 11-23 * [I] 3,21;
 [A]RU2292145  (FEDERAL NOE G OBRAZOVATEL NOE [RU]) [A] 1-21 * abstract *;
 [X]US2008213320  (EISENSTEIN MAYER [US], et al) [X] 20,21 * paragraph [0045]; claims 1,8,11,30 *;
 [A]US2009110674  (LOIZOU NICOS C [US]) [A] 1-21 * claims 1-8, column 2, lines 30-51, column 3, lines 30-33, examples 1-4;; claim 1 *;
 [A]  - SHAH N ET AL, "SURVIVAL OF LACTIC ACID BACTERIA AND THEIR LACTASES UNDER ACIDIC CONDITIONS", JOURNAL OF FOOD SCIENCE, (1990), vol. 55, no. 2, ISSN 0022-1147, pages 506 - 509, XP002638655 [A] 1-21 * figure 2, page 509, left column, last para, lines 1-7; abstract *

DOI:   http://dx.doi.org/10.1111/j.1365-2621.1990.tb06797.x
by applicantUS4034115
 DE2725731
 WO9534292
 WO9606924
 DE69505374T
 US6008027
 EP1112002
 US6410018
 US6428786
 US6562338
 US6562339
 WO2004089290
 RU2292145
 DE69535290T
 US2008187525
 US2008213320
 US2008260708
 US2009110674
 WO2009056979
    - GUARNER ET AL., BRIT. J. NUTRITION, (2005), vol. 93, pages 783 - 786
    - HOVE ET AL., AMER. J. CLIN. NUTR., (1994), vol. 59, pages 74 - 79
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.